An evaluation of the efficacy of the toe brachial index measuring vascular involvement in systemic sclerosis and other connective tissue diseases

Yoshinao Muro, Kazumitsu Sugiura, Yukiko Morita, Yasushi Tomita

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objective. The ankle and toe brachial indices (ABI and TBI) are calculated as the ankle and toe systolic blood pressures divided by the highest brachial systolic pressure, respectively. We sought to evaluate the efficacy of ABI and TBI as an objective, non-invasive assessment of vascular involvement in patients with systemic sclerosis (SSc) and to investigate the clinical significance of TBI in SSc. Methods. ABI and TBI were measured using an oscillometric method in 136 outpatients, including 77 with SSc, 29 with systemic lupus erythematosus (SLE), 16 with primary Sjögren's syndrome (SjS), and 14 with dermatomyositis (DM). We also analyzed 21 healthy controls. Results. The mean ABI and frequency of reduced ABI values (<1.0) did not differ significantly between disease groups. TBI values in patients with SSc and lSSc were significantly lower than in those with SjS and DM, respectively (p<0.01). Patients with SSc and lSSc had significantly lower TBI values than healthy controls (p<0.05). Reduced TBI values (<0.6) were significantly more common in patients with SSc, including both dSSc and lSSc, than in those with SLE (p<0.05). Similarly, the frequency of decreased TBI was higher in patients with SSc and dSSc than in those with SjS or healthy controls (p<0.05). Skin ulcers (p=0.041) or overlap with rheumatoid arthritis (p=0.018) were associated with reduced TBI values by logistic regression analysis. Conclusion. The TBI value is a useful, non-invasive tool to evaluate vascular involvement in SSc.

Original languageEnglish
JournalClinical and Experimental Rheumatology
Volume27
Issue number3 SUPPL. 54
Publication statusPublished - 29-10-2009
Externally publishedYes

Fingerprint

Ankle Brachial Index
Connective Tissue Diseases
Systemic Scleroderma
Blood Vessels
Dermatomyositis
Blood Pressure
Systemic Lupus Erythematosus
Skin Ulcer
Toes
Ankle
Rheumatoid Arthritis
Arm
Outpatients
Logistic Models
Regression Analysis

All Science Journal Classification (ASJC) codes

  • Immunology
  • Immunology and Allergy
  • Rheumatology

Cite this

@article{f24f4fd9cbbe4c52ae4d2e7ccad97bf6,
title = "An evaluation of the efficacy of the toe brachial index measuring vascular involvement in systemic sclerosis and other connective tissue diseases",
abstract = "Objective. The ankle and toe brachial indices (ABI and TBI) are calculated as the ankle and toe systolic blood pressures divided by the highest brachial systolic pressure, respectively. We sought to evaluate the efficacy of ABI and TBI as an objective, non-invasive assessment of vascular involvement in patients with systemic sclerosis (SSc) and to investigate the clinical significance of TBI in SSc. Methods. ABI and TBI were measured using an oscillometric method in 136 outpatients, including 77 with SSc, 29 with systemic lupus erythematosus (SLE), 16 with primary Sj{\"o}gren's syndrome (SjS), and 14 with dermatomyositis (DM). We also analyzed 21 healthy controls. Results. The mean ABI and frequency of reduced ABI values (<1.0) did not differ significantly between disease groups. TBI values in patients with SSc and lSSc were significantly lower than in those with SjS and DM, respectively (p<0.01). Patients with SSc and lSSc had significantly lower TBI values than healthy controls (p<0.05). Reduced TBI values (<0.6) were significantly more common in patients with SSc, including both dSSc and lSSc, than in those with SLE (p<0.05). Similarly, the frequency of decreased TBI was higher in patients with SSc and dSSc than in those with SjS or healthy controls (p<0.05). Skin ulcers (p=0.041) or overlap with rheumatoid arthritis (p=0.018) were associated with reduced TBI values by logistic regression analysis. Conclusion. The TBI value is a useful, non-invasive tool to evaluate vascular involvement in SSc.",
author = "Yoshinao Muro and Kazumitsu Sugiura and Yukiko Morita and Yasushi Tomita",
year = "2009",
month = "10",
day = "29",
language = "English",
volume = "27",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "3 SUPPL. 54",

}

An evaluation of the efficacy of the toe brachial index measuring vascular involvement in systemic sclerosis and other connective tissue diseases. / Muro, Yoshinao; Sugiura, Kazumitsu; Morita, Yukiko; Tomita, Yasushi.

In: Clinical and Experimental Rheumatology, Vol. 27, No. 3 SUPPL. 54, 29.10.2009.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An evaluation of the efficacy of the toe brachial index measuring vascular involvement in systemic sclerosis and other connective tissue diseases

AU - Muro, Yoshinao

AU - Sugiura, Kazumitsu

AU - Morita, Yukiko

AU - Tomita, Yasushi

PY - 2009/10/29

Y1 - 2009/10/29

N2 - Objective. The ankle and toe brachial indices (ABI and TBI) are calculated as the ankle and toe systolic blood pressures divided by the highest brachial systolic pressure, respectively. We sought to evaluate the efficacy of ABI and TBI as an objective, non-invasive assessment of vascular involvement in patients with systemic sclerosis (SSc) and to investigate the clinical significance of TBI in SSc. Methods. ABI and TBI were measured using an oscillometric method in 136 outpatients, including 77 with SSc, 29 with systemic lupus erythematosus (SLE), 16 with primary Sjögren's syndrome (SjS), and 14 with dermatomyositis (DM). We also analyzed 21 healthy controls. Results. The mean ABI and frequency of reduced ABI values (<1.0) did not differ significantly between disease groups. TBI values in patients with SSc and lSSc were significantly lower than in those with SjS and DM, respectively (p<0.01). Patients with SSc and lSSc had significantly lower TBI values than healthy controls (p<0.05). Reduced TBI values (<0.6) were significantly more common in patients with SSc, including both dSSc and lSSc, than in those with SLE (p<0.05). Similarly, the frequency of decreased TBI was higher in patients with SSc and dSSc than in those with SjS or healthy controls (p<0.05). Skin ulcers (p=0.041) or overlap with rheumatoid arthritis (p=0.018) were associated with reduced TBI values by logistic regression analysis. Conclusion. The TBI value is a useful, non-invasive tool to evaluate vascular involvement in SSc.

AB - Objective. The ankle and toe brachial indices (ABI and TBI) are calculated as the ankle and toe systolic blood pressures divided by the highest brachial systolic pressure, respectively. We sought to evaluate the efficacy of ABI and TBI as an objective, non-invasive assessment of vascular involvement in patients with systemic sclerosis (SSc) and to investigate the clinical significance of TBI in SSc. Methods. ABI and TBI were measured using an oscillometric method in 136 outpatients, including 77 with SSc, 29 with systemic lupus erythematosus (SLE), 16 with primary Sjögren's syndrome (SjS), and 14 with dermatomyositis (DM). We also analyzed 21 healthy controls. Results. The mean ABI and frequency of reduced ABI values (<1.0) did not differ significantly between disease groups. TBI values in patients with SSc and lSSc were significantly lower than in those with SjS and DM, respectively (p<0.01). Patients with SSc and lSSc had significantly lower TBI values than healthy controls (p<0.05). Reduced TBI values (<0.6) were significantly more common in patients with SSc, including both dSSc and lSSc, than in those with SLE (p<0.05). Similarly, the frequency of decreased TBI was higher in patients with SSc and dSSc than in those with SjS or healthy controls (p<0.05). Skin ulcers (p=0.041) or overlap with rheumatoid arthritis (p=0.018) were associated with reduced TBI values by logistic regression analysis. Conclusion. The TBI value is a useful, non-invasive tool to evaluate vascular involvement in SSc.

UR - http://www.scopus.com/inward/record.url?scp=70350291551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350291551&partnerID=8YFLogxK

M3 - Article

VL - 27

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 3 SUPPL. 54

ER -